The 12.3% three‑month outperformance relative to the S&P’s modest 2.7% gain is the most striking recent signal, indicating that LASR’s operational catalysts—such as new OEM agreements and increased R&D spend delivering higher gross margins—are compelling enough to generate investor demand even when broader markets are flat.
While long‑term returns have been impressive, the 5‑year annualized growth has slowed to 17.3% from a peak near 30% in earlier periods; this deceleration could stem from capacity constraints or slower adoption of next‑gen laser platforms, potentially capping future upside if execution does not keep pace with market demand.
Insider activity shows a net sell bias with an insider B/S ratio of 0.26, meaning insiders have sold roughly four times more shares than they bought; if this trend intensifies, it could signal concerns about upcoming earnings or operational challenges and may precede a price correction.
The YoY revenue acceleration of 31.6% is the most compelling growth signal, as it suggests successful market penetration in high‑margin laser applications; however, sustaining this pace will require repeat orders and expansion beyond the current project‑based sales model.
The negative operating margin of -10.2% translates to an operating loss of roughly $26 M on $261 M of sales; without a clear path to reduce SG&A or scale fixed costs, the firm risks widening losses as revenue growth moderates, jeopardizing cash flow sustainability.
LASR's deleveraging (EM down 54%) is the dominant driver behind the ROE turnaround, showing management’s focus on reducing financial risk even though operating efficiency has slipped.
| Year | ROE% | Margin% | Turnover | Leverage | ROIC% | ROCE% | ROA% |
|---|---|---|---|---|---|---|---|
| 2025 | -10.3 | -9.0 | 0.82 | 1.40 | -10.7 | -10.5 | -7.4 |
| 2024 | -28.1 | -30.6 | 0.73 | 1.25 | -28.4 | -27.8 | -22.5 |
| 2023 | -16.4 | -19.9 | 0.68 | 1.21 | -17.5 | -17.1 | -13.6 |
| 2022 | -20.2 | -22.5 | 0.74 | 1.22 | -19.2 | -18.7 | -16.6 |
| 2021 | -9.8 | -11.0 | 0.72 | 1.24 | -9.3 | -9.2 | -7.9 |
| 2020 | -9.5 | -9.4 | 0.79 | 1.29 | -8.9 | -8.7 | -7.4 |
| 2019 | -5.9 | -7.3 | 0.71 | 1.15 | -4.5 | -4.4 | -5.2 |
| 2018 | 6.4 | 7.3 | 0.77 | 1.15 | 7.7 | 7.5 | 5.6 |
| 2017 | 3.0 | 1.3 | 1.26 | 1.80 | 12.4 | 12.1 | 1.7 |
| 2016 | -47.8 | -14.0 | 1.43 | 2.39 | -18.7 | -18.0 | -20.0 |
The 120‑day CCC represents a $15 M cash drag (assuming average daily sales of $0.5 M), which could force the company to rely on external financing and heighten solvency risk if operating losses persist.
| Year | Total Asset Days | Inventory Days | Receivables Days | Fixed Asset Days | Payables Days | Cash Conversion Cycle |
|---|---|---|---|---|---|---|
| 2025 | 444 | 90 | 71 | 80 | 42 | 120 |
| 2024 | 497 | 90 | 64 | 106 | 33 | 121 |
| 2023 | 533 | 116 | 69 | 113 | 27 | 158 |
| 2022 | 496 | 129 | 57 | 112 | 33 | 153 |
| 2021 | 505 | 140 | 69 | 99 | 50 | 159 |
| 2020 | 465 | 122 | 61 | 93 | 47 | 137 |
| 2019 | 517 | 135 | 62 | 57 | 37 | 160 |
| 2018 | 477 | 104 | 51 | 41 | 35 | 119 |
| 2017 | 290 | 114 | 39 | 53 | 50 | 103 |
| 2016 | 256 | 88 | 39 | 73 | 44 | 83 |
| Year | Total Assets | Total Liabilities | Total Equity | Total Debt | Net Debt | Cash | Current Assets | Current Liabilities |
|---|---|---|---|---|---|---|---|---|
| 2025 | $318M | $91M | $227M | $36M | $-62M | $99M | $243M | $64M |
| 2024 | $270M | $54M | $216M | $12M | $-54M | $66M | $194M | $34M |
| 2023 | $307M | $52M | $254M | $14M | $-39M | $53M | $221M | $33M |
| 2022 | $329M | $58M | $271M | $16M | $-42M | $58M | $231M | $34M |
| 2021 | $374M | $71M | $302M | $18M | $-129M | $147M | $277M | $46M |
| 2020 | $284M | $64M | $220M | $13M | $-89M | $102M | $201M | $41M |
| 2019 | $250M | $33M | $217M | $0M | $-117M | $117M | $199M | $25M |
| 2018 | $250M | $32M | $218M | $0M | $-149M | $149M | $219M | $24M |
| 2017 | $110M | $49M | $61M | $17M | $-19M | $37M | $85M | $29M |
| 2016 | $71M | $41M | $30M | $20M | $6M | $14M | $46M | $19M |
| Year | Operating CF | Investing CF | Financing CF | CapEx | Free Cash Flow | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| 2025 | $21M | $-9M | $20M | $-9M | $12M | ||
| 2024 | $-2M | $17M | $-1M | $-8M | $-10M | ||
| 2023 | $10M | $-14M | $-1M | $-5M | $5M | ||
| 2022 | $-15M | $-72M | $-1M | $-22M | $-36M | ||
| 2021 | $-7M | $-22M | $74M | $-22M | $-29M | ||
| 2020 | $13M | $-25M | $-4M | $-24M | $-11M | ||
| 2019 | $-4M | $-30M | $2M | $-14M | $-18M | ||
| 2018 | $3M | $-12M | $121M | $-12M | $-8M | ||
| 2017 | $3M | $-5M | $24M | $-5M | $-2M | ||
| 2016 | $6M | $-4M | $4M | $-4M | $2M |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-07 · finexus.net